Cecilia Montiel-Nava is director of the Behavior and Child Development Lab and associate professor of psychological science at the University of Texas Rio Grande Valley in Edinburg, Texas.
Countries across Latin America and the Caribbean struggle to collect data on autism, but Cecilia Montiel-Nava and the Latin American Autism Spectrum Network are beginning to change that.
From this contributor
Filling autism knowledge gaps in Latin America: Q&A with Cecilia Montiel-Nava
Filling autism knowledge gaps in Latin America: Q&A with Cecilia Montiel-Nava
Cecilia Montiel-Nava
Associate professor
University of Texas Rio Grande Valley
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.